Discover investment opportunities in Best AI Biotech Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best AI Biotech Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best AI Biotech Stocks using our Smart AI Filter.
8 stocks found for "Best AI Biotech Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.35 | ±84.8% | -1.1 | 0.00% | |||
1.19 | ±46.0% | -133.7 | 0.00% | |||
0.36 | ±26.9% | 24.5 | 0.00% | |||
1.21 | ±61.6% | -8.4 | 0.00% | |||
1.34 | ±55.5% | -10.4 | 0.00% | |||
0.89 | ±41.9% | 22.8 | 0.00% | |||
1.77 | ±71.4% | -18.6 | 0.00% | |||
1.19 | ±53.7% | -156.9 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How does Invitae Corporation (NVTA) position itself in the AI and biotech sectors?
A: Invitae (NVTA) integrates AI with genetic testing, offering extensive cost-effective genetic information. It leverages AI in data analysis to advance in diagnostics, personalized medicine, and research, although rapid technological changes pose risks.
Q: What growth opportunities exist for Vertex Pharmaceuticals (VRTX) in AI-driven biotech?
A: Vertex (VRTX) is known for cystic fibrosis treatments and explores AI for drug discovery and personalized medicine. It leverages AI to potentially streamline development processes, but must navigate data accuracy and investment return uncertainties.
Q: How does Align Technology (ALGN) incorporate AI in its operations?
A: Align Technology (ALGN) uses AI in its Invisalign system for custom orthodontic solutions. AI aids in precision and efficiency, crucial for product innovation. However, competitive pressure and technology adoption challenges need consideration.
Q: What role does AI play in Regeneron Pharmaceuticals' (REGN) product development?
A: Regeneron Pharmaceuticals (REGN) employs AI to enhance its drug development process, including antibody discovery. AI aims to improve R&D efficiency, but regulatory hurdles and data validation issues remain critical challenges.
Q: In what ways does BioMarin Pharmaceutical (BMRN) leverage AI technologies?
A: BioMarin Pharmaceutical (BMRN), focused on rare diseases, explores AI to accelerate drug discovery and optimize therapies. This approach could enhance clinical outcomes but involves risks related to data integrity and algorithm effectiveness.
Q: What impact does AI have on Illumina's (ILMN) genomic sequencing efforts?
A: Illumina (ILMN) integrates AI in genomic sequencing to improve data processing, accuracy, and personalized health solutions. AI innovations could boost scalability, though expensive R&D and evolving market dynamics pose risks.
Michael Yee, Jefferies senior biotech analyst, joins CNBC's 'Squawk on the Street' to discuss how AI could fuel drug discovery and development, the timeline for when pharmaceutical companies could see benefits from AI, and more.
Read more